Itron (ITRI) PT Lowered to $50 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ITRI Hot Sheet
Price: $98.81 -0.05%
Rating Summary:
16 Buy, 16 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
16 Buy, 16 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley analyst Connor Lynagh lowered the price target on Itron (NASDAQ: ITRI) to $50.00 (from $55.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
